3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Endocrine
1
Breast
1
Conditions
Prostatic Neoplasms
22
Breast Neoplasms
21
Polycystic Ovary Syndrome
12
Carcinoma, Non-Small-Cell Lung
11
Colorectal Neoplasms
10
Lung Neoplasms
8
Endometrial Neoplasms
7
Pancreatic Neoplasms
6
Neoplasms
6
Glioblastoma
5
Rectal Neoplasms
4
Melanoma
4
Lymphoma, Large B-Cell, Diffuse
4
Insulin Resistance
4
Adenocarcinoma of Lung
4
Adenocarcinoma
4
Uterine Cervical Neoplasms
3
Leukoplakia, Oral
3
Urinary Bladder Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
2
Obesity
2
Neoplasm Metastasis
2
Liver Neoplasms
2
Leukemia, Myeloid, Acute
2
Hyperandrogenism
2
Esophageal Neoplasms
2
Erythroplasia
2
Endometrial Hyperplasia
2
Diabetes Mellitus
2
Colonic Neoplasms
2
Interventions
Fulvestrant
2
Alpelisib
2
exemestane
1
dapagliflozin
1
Vildagliptin
1
Tamoxifen
1
Metformin
1
Letrozole
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Hyperglycemia
×
Metformin
×
Clear all
NCT04300790
2025-07-29
METALLICA
MedSIR
Phase 2
Completed
69 enrolled